SEC Filings
Form 13F
Form 13F is the quarterly disclosure that institutional investment managers overseeing at least $100 million file with the SEC, listing their U.S. equity holdings. It lets investors track which funds are building or exiting biotech positions.
- Category
- SEC Filings
Prepared research question
How does Form 13F affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
Form 13F is the quarterly disclosure that institutional investment managers overseeing at least $100 million file with the SEC, listing their U.S. equity holdings. It lets investors track which funds are building or exiting biotech positions.
Related terms
From term to thesis rule
Investigate how Form 13F changes a biotech thesis
Define when Form 13F should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.